Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

M.V. Maraldo, F. Giusti, I.R. Vogelius, M. Lundemann, M.A.E. van der Kaaij, S. Ramadan, B. Meulemans, M. Henry-Amar, B.M.P. Aleman, J. Raemaekers, P. Meijnders, E.C. Moser, H.C. Kluin-Nelemans, P. Feugier, O Casasnovas, C. Fortpied, L. Specht

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)E492-E502
JournalLancet haematology
Volume2
Issue number11
DOIs
Publication statusPublished - 2015

Cite this

Maraldo, M. V., Giusti, F., Vogelius, I. R., Lundemann, M., van der Kaaij, M. A. E., Ramadan, S., ... Specht, L. (2015). Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet haematology, 2(11), E492-E502. https://doi.org/10.1016/S2352-3026(15)00153-2